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Background: The correlation between impedance cardiography (ICG) and 6 min walk distance (6MWD) in atrial
fibrillation (AF) patients remains unknown.
Methods: We recruited 49 subjects in the study (21 AF patients and 28 patients without AF) and estimated
hemodynamic parameters: cardiac output (CO), stroke volume (SV), stroke volume index (SVI), left stroke work (LSW),
left stroke work index (LSWI), stroke systemic vascular resistance (SSVR), stroke systemic vascular resistance index (SSVRI);
6MWD, left ventricle ejection fraction (LVEF), NT-pro brain natriuretic peptide (NT-pro BNP) for the two groups.
Results: The AF group have apparently lower CO (2.26 ± 0.14 VS 4.11 ± 0.20 L/min, p = 0.039) and distinctly higher SVR
(677.60 ± 69.10 VS 344.41 ± 22.98 dynes/cm5, p = 0.001), SSVRI (396.97 ± 36.80 VS 199.01 ± 11.72 dynes/cm5/m2, p < 0.
001) than the control group. NT-pro BNP (1409.48 ± 239.90 VS 332.59 ± 68.85 pg/ml, p = 0.001) in the AF group was
significantly higher than the control group and 6MWD (264.33 ± 14.55 VS 428.79 ± 29.98 m, p < 0.001) in the
AF group was lower than the control group. There was no significant difference in LVEF between the two groups
(62.67 ± 7.62 % VS 63.93 ± 5.03 %, p = 0.470). Pearson correlation analysis revealed that CO (R = 0.494, p = 0.023), SV
(R = 0.633, p = 0.002), LSW (R = 0.615, p = 0.003) and LSWI (R = 0.491, p = 0.024) significantly correlated positively with
6MWD in AF patients.
Conclusions: AF patients had lower cardiac output, shorter 6MWD and higher NT-pro BNP than patients with sinus
rhythm. The cardiac output measured by impedance cardiography significantly correlated positively with 6MWD in
AF patients.
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Atrial fibrillation (AF) is a kind of common cardiac
arrhythmia [1], which disrupts the movement of the left
atrial. AF is defined as an irregular, disorganized elec-
trical activity of the atria and it is a growing clinical
problem associated with increased morbidity and mor-
tality [2, 3]. Estimating cardiac function in AF patients
contributes to judge prognosis and adjust therapeutic
schedule. Traditionally, left ventricle ejection fraction* Correspondence: zhouhonglian63@163.com
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(http://creativecommons.org/publicdomain/ze(LVEF), the fraction of outbound blood pumped from
the heart with each heartbeat measured by cardiac color
ultrasound (CCU) has been chosen to assess the cardiac
function in patients including AF. However, stroke
volume changed in different cardiac cycles because of
irregular diastole and systole of the atria [3, 4]. Lacking
of an active contraction of the LA (atrial kick) in late
diastole, cardiac output in AF patients may be less than
in normal persons. LVEF measured by CCU only reflect
cardiac function of contraction in one cardiac cycle, not
the whole cardiac function in AF patients.
A considerable proportion of previous data have stated
the role of hemodynamic parameters measured by
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[5–7] and pulmonary hypertension [8]. ICG is a reliable,
noninvasive technique that can be easily used to con-
tinually measure hemodynamic parameters and output
the mean values [9]. ICG is based on the Ohm’s law
stating that when a constant current travels through a
conductor, changes in voltage are directly proportional
to variations in impedance [9]. Bio-impedance decreases
across the chest during systole as a result of an increase
in aortic blood volume and flow velocity. There are
series of hemodynamic parameters associated with
cardiac function such as cardiac output (CO), stroke
volume (SV), stroke volume index (SVI), left stroke work
(LSW), left stroke work index (LSWI), stroke systemic
vascular resistance (SSVR) and stroke systemic vascular
resistance index (SSVRI) measured by ICG.
Gilewski et al. investigated cardiovascular changes in
tissue Doppler echocardiography (TDE) and ICG in AF
patients subjected to cardioversion [10]. The study sug-
gest that ICG seems to be complementary to standard
echocardiography, and to some extent to surpass TDE.
However, there is little published study on the correl-
ation between ICG and 6 min walk distance (6MWD) or
the value of ICG in predicting the cardiac function in
AF patients. Although AF patients have irregular diastole
period, ICG could continually measure parameters re-
lated to cardiac function, which provides more accurate
information to predict the cardiac condition in AF
patients. The present study will research the values of
impedance cardiography in predicting cardiac function
and the correlation between hemodynamic parameters
and 6MWD in AF patients.
Methods
Study sample
This study was approved by the Clinical Research Ethics
Committee of Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology. All
participating persons were given informed consent and
written informed consent was obtained from all subjects
before enrollment. The study was performed between
January 2014 and December 2015. We recruited patients
with AF (n = 21) and healthy controls (n = 28). All the
AF patients in our study were persistent or longstanding
persistent AF according to 2014 AHA/ACC/HRS guide-
line [11]. Patients in healthy control group were sinus
rhythm confirmed by electrocardiogram and ambulatory
electrocardiogram. Patients in the two groups were
matching for age, gender, height, weight, body mass
index (BMI), underlying disease and medicine.
Exclusion criteria were impaired cognition, chronic
obstructive pulmonary diseases (COPD), hyperthyroid-
ism, severe hepatic disease, severe renal impairment,
asthma, cystic, fibrosis, arthritis, ankle, knee or hipinjuries, muscle wasting, any life-threatening disease, drugs
and/or alcohol abuse [12, 13]. Additionally, we excluded
patients with pacemaker implantation, valvular heart dis-
ease, enlarged LV dimension, recent myocardial infarction,
unstable angina, candidacy for revascularization, cardiomy-
opathy, congestive heart failure, pulmonary heart disease, a
resting heart rate of more than 120 bpm, a systolic blood
pressure of more than 180 mmHg, and a diastolic blood
pressure of more than 100 mmHg [10, 12, 13].
Data collection
ICG was performed using the Cheer Sails Medical
(CSM3000 system) with electrodes placed on the neck
and in the hypochondriac regions. The basic principle of
this methodology is that variations in the impedance (Z)
to an alternating high-frequency (75KHz) and low mag-
nitude (1.8 mA) current, across the thorax during car-
diac ejection, result in a specific waveform that can be
used to calculate stroke volume [14]. After 5 min of rest
in the supine position in an examination room, a techni-
cian performed ICG. The hemodynamic variables CO,
SV, SVI, LSW, LSWI, SVR, and SVRI referring to the
cardiac function and health condition were showed.
Values of the hemodynamic parameters represented the
mean value over the 3-minute sampling period.
CCU was performed with the aim of measuring LVEF.
Diastolic left ventricular diameter (DLVD), left ventricular
posterior wall thickness (LVPWT), interventricular septal
thickness (IVST) and left atrial diameter (LAD) were also
recorded. The 6MWT was performed according to stand-
ard guideline [12]. A single walk test without practice was
administered. The 6 min walk test (6MWT) was ordered
by the patient’s physicians as an initial or follow-up assess-
ment of their cardiac function according to Automatic
Test System (ATS) standards [12, 13]. All distance data
were recorded accurately. NT-pro BNP were tested by
picking venous blood in clinical laboratory.
Data analysis
Baseline subject characteristics across quartiles were
compared using independent-samples t test for con-
tinuous variables and Pearson χ2 test for dichotomous
variables [15, 16]. All the statistic values of continuous
variables was mean ± standard error. In χ2 test, continu-
ity correction was for dichotomous variables with fewer
than 5 participants in a categories. Statistical significance
was set to a p value less than 0.05. The strength of asso-
ciation between variables was performed using Pearson
correlation test [17].
Results
Baseline characteristics of the AF group and the control
group were presented in Table 1. The subjects in the
two groups had no statistical difference in age, gender,
Table 1 Baseline characteristics of all the subjects
Parameters Control group (n = 28) AF group (n = 21) t/χ2 P
Age (years) 75.36 ± 2.23 83.19 ± 2.0 2.523 0.093
Gender, n (% Male) 20 (71.4) 17 (81.0) 0.589 0.443
Height (cm) 166.07 ± 1.79 164.76 ± 1.47 −0.540 0.043
Weight (kg) 65.25 ± 2.184 61.57 ± 2.260 −1.152 0.421
BMI (kg2/m) 23.52 ± 0.52 22.68 ± 0.79 −0.929 0.191
Heart rate (bpm) 68.50 ± 1.99 68.90 ± 2.24 0.135 0.890
SBP (mmHg) 120.57 ± 2.91 120.43 ± 3.83 −0.030 0.676
DBP (mmHg) 67.25 ± 1.73 69.00 ± 1.63 0.715 0.279
Hypertension, n (%) 20 (71.4) 18 (85.7) 0.706 0.401
T2DM, n (%) 4 (14.3) 3 (14.3) 0 1.000
CRD, n(%) 2(7.1) 1(4.8) 0.118 1.000
CAD, n(%) 4(14.3) 2(9.5) 0.253 0.688
β-blocker treatment, n (%) 8 (28.6) 7 (33.3) 0.128 0.720
Digoxin treatment, n (%) 0 (0) 5 (23.8) 5.053 0.025
Abbreviations: BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, T2DM type 2 diabetes mellitus, CRD chronic renal disease,
CAD coronary artery disease
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mellitus and hypertension or basic medicine such as
β-receptor blocker. There were five (23.8 %) patients in
the AF group using digoxin and nobody in the control
group using the same medicine, which made statistical
difference in the two groups.
Table 2 defined the comparison of hemodynamic
parameters, 6MWD, LVEF and NT-pro BNP between
the AF group and the control group. The present study
found that the 6MWD in AF patients was shorter than
the control group (264.33 ± 14.55 VS 428.79 ± 29.98 m,
p < 0.001). The patients in the AF group had apparently
lower CO (2.26 ± 0.14 VS 4.11 ± 0.20 L/min, p = 0.039)
and distinctly higher SVR (677.60 ± 69.10 VS 344.41 ±
22.98 dynes/cm5, p = 0.001), SSVRI (396.97 ± 36.80 VS
199.01 ± 11.72 dynes/cm5/m2, p < 0.001) than those in
the control group. NT-pro BNP (1409.48 ± 239.90 VS
332.59 ± 68.85 pg/ml, p = 0.001) in the AF group was sig-
nificantly higher than the control group. There was no
significant difference in LVEF between the two groups
(62.67 ± 7.62 % VS 63.93 ± 5.03 %, p = 0.470). No signifi-
cant difference was observed in other measured echocar-
diographic parameters (Table 2).
As shown in Table 3, Pearson correlation analysis
revealed that CO (R = 0.494, p = 0.023), SV (R = 0.633,
p = 0.002), LSW (R = 0.615, p = 0.003) and LSWI (R =
0.491, p = 0.024) significantly correlated positively with
6MWD. LVEF did not significantly correlate with 6MWD
(R = 0.037, p = 0.803).
Discussion
In previous published study, non-invasive impedance car-
diography has been used to reveal heterogeneity ofhemodynamic parameters in primary hypertension [18, 19]
and guide antihypertensive therapy [19–21]. However,
there is no published data studying the role of impedance
cardiography in patients with atrial fibrillation or the cor-
relation between hemodynamic parameters and 6MWD.
In the present study, we explored the feature of
hemodynamic parameters in AF patients and statistical
correlation among hemodynamic parameters, LVEF,
NT-pro BNP and 6MWD.
6MWT is used to measure the distance that a patient
can quickly walk on a flat, hard surface in a period of
6 min [12], and 6MWD is the distance in 6MWT. Due
to wide availability, security and ease of implementation,
6MWT had been used in the assessment of functional
capacity, evaluating exercise tolerance, prognosis and
therapeutic effectiveness in patients with impaired car-
diac function [22–27]. The present study found that
6MWD in AF patients was shorter than the control
group (264.33 ± 14.55 VS 428.79 ± 29.98 m, p < 0.001)
whereas LVEF had no significant difference between the
AF group and the control group (62.67 ± 7.62 % VS
63.93 ± 5.03 %, p = 0.470). Our study also found that LVEF
did not correlate with 6MWD (R = 0.037, p = 0.803). The
result suggested that LVEF could not predict cardiac
function accurately in AF patients.
BNP levels could be higher in patients with impaired
cardiac function [26, 28]. The present data showed that
AF patients had significantly higher NT-pro BNP than
the control group (1385.74 ± 1102.51 VS 404.54 ±
322.33 pg/ml, p < 0.001). Although the value of LVEF in
AF patients remained normal in the present study, the
cardiac function in the AF group was worse than the
control group according to the 6MWD and NT-pro BNP.
Table 2 Comparison of hemodynamic, 6MWD, LVEF, NT-pro BNP between the control group and the AF group
Parameter Control group (n = 28) AF group (n = 21) t p
ICG parameters
CO (L/min) 4.11 ± 0.20 2.26 ± 0.14 4.502 0.039
SV (mL) 60.28 ± 3.30 32.45 ± 2.55 0.885 0.352
SVI (mL/m2) 34.93 ± 1.61 18.89 ± 1.74 0.086 0.771
SVR (dynes/cm5) 344.41 ± 22.98 677.60 ± 69.10 11.549 0.001
SVRI (dynes/cm5/m2) 199.01 ± 11.72 396.97 ± 36.80 14.556 <0.001
LSW (gm-m/beat) 66.42 ± 3.72 37.03 ± 2.77 3.429 0.070
LSWI (gm-m/m2/beat) 38.96 ± 1.85 22.42 ± 1.59 2.421 0.126
CCU parameters
LVEF (%) 64.57 ± 0.92 63.05 ± 1.84 3.307 0.075
LAD (mm) 33.86 ± 1.00 40.67 ± 1.71 3.634 0.164
DLVD (mm) 44.96 ± 0.72 46.67 ± 1.44 1.140 0.056
IVST (mm) 10.21 ± 0.24 9.95 ± 0.24 0.781 0.586
LVPWT (mm) 9.89 ± 0.22 9.75 ± 0.20 0.489 0.981
Other parameters
NT-pro BNP (pg/ml) 332.59 ± 68.85 1409.48 ± 239.90 13.470 0.001
6MWD (m) 428.79 ± 29.98 264.33 ± 14.55 16.816 <0.001
Abbreviations: AF atrial fibrillation, ICG impedance cardiography, 6MWD 6 min walk distance, LVEF left ventricle ejection fraction, NT-pro BNP plasma NT-pro brain
natriuretic peptide, CO cardiac output, SV stroke volume, SVI stroke volume index, SSVR stroke systemic vascular resistance, SSVRI stroke systemic vascular resistance index,
LSW left stroke work, LSWI left stroke work index, CCU cardiac color ultrasound, LAD left atrial diameter, DLVD diastolic left ventricular diameter, IVST interventricular
septal thickness, LVPWT left ventricular posterior wall thickness
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in the diagnosis, prognosis and therapy in a variety of
diseases [20, 21]. A recent study of AF patients subjected
to cardioversion suggests that ICG seems to be comple-
mentary to standard echocardiography, and to some ex-
tent to surpass TDE [10]. The present study discovered
that the CO (2.26 ± 0.14 VS 4.11 ± 0.20 L/min, p = 0.039)
measured by impedance cardiography in AF patients were
lower than the control group. Our data also found that
CO (R = 0.494, p = 0.023), SV (R = 0.633, p = 0.002), LSW
(R = 0.615, p = 0.003) and LSWI (R = 0.491, p = 0.024)
correlated positively with 6MWD. Lacking of the atrialTable 3 Correlation between hemodynamic parameters, LVEF
and 6MWD in all patients
Parameters Control group R p AF group R P
CO (L/min) 0.626 <0.001 0.494 0.023
SV (mL) 0.587 0.001 0.633 0.002
SVI (mL/m2) 0.518 0.005 0.512 0.018
SVR (dynes/cm5) −0.261 0.179 −0.331 0.143
SVRI (dynes/cm5/m2) −0.389 0.041 −0.413 0.063
LSW (gm-m/beat) 0.488 0.008 0.615 0.003
LSWI (gm-m/m2/beat) 0.488 0.008 0.491 0.024
LVEF (%) 0.106 0.591 −0.307 0.176
NT-pro BNP (pg/ml) −0.503 0.006 0.378 0.091
Abbreviation: R Correlation coefficientkick in late diastole [4], the cardiac output in AF patients
was lower than the non AF patients. With lower cardiac
output, the AF patients generally have shorter 6MWD.
6MWD had been proved to be useful and reliable in
the assessment of functional capacity, evaluating exercise
tolerance, prognosis and therapeutic effectiveness in
patients with impair cardiac function [22, 29, 30]. The
present study detected that hemodynamic parameters
had a significant correlation with the 6MWD whereas
LVEF measurements correlated poorly with the 6MWD
in AF patients. The results of this study suggest that
hemodynamic parameters measured by ICG could provide
more accurate information than LVEF to predict cardiac
function in AF patients. It is noteworthy that all the AF
patients in our study were persistent or longstanding
persistent AF, and we excluded AF patients with obviously
abnormal heart structure. This strengthen the novelty of
the present study.
Clinical implications
Digitalis and beta-blockers have long been used to control
heart rate in AF patients in order to reduce AF-related
symptoms [31, 32]. The main hemodynamic change fol-
lowing the treatment with beta-blockers is a decrease of
cardiac output. Digoxin therapy could increase the cardiac
output and offer symptomatic improvement in AF pa-
tients with decreased cardiac output and cardiac function
[33, 34]. Therefore, evaluating the cardiac output and
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value of LVEF in AF patients remained normal in the
present study, the cardiac function in the AF patients was
worse than the control group according to the 6MWD
and NT-pro BNP. Our study also found that cardiac out-
put measured by ICG significantly correlated positively
with 6MWD in AF patients, and LVEF did not correlate
with 6MWD. Clinical doctors may adjust therapeutic
schedule of digitalis and beta-blockers according to the
information from ICG. This is just our speculation ac-
cording to our finding and the specific application need
further investigation.Study limitations
Our study has limitations: (1) The study sample was
relatively small, limiting the statistical power of group
analyses. (2) The subjects in our study were relatively
old and their parameters maybe could not represent the
condition of the whole population. (3) We did not pro-
vide some important echocardiographic parameters such
as cardiac index and left ventricular end-diastolic vol-
ume. Whether the diastolic dysfunction contribute to
the decreased cardiac output in AF patients is not clear.
Further studies are needed to determine the mechanism
underlying the hemodynamic disorders observed in AF.Conclusion
Compared to patients with sinus rhythm, AF patients
had lower cardiac output, shorter 6MWD and higher
NT-pro BNP. The cardiac output measured by imped-
ance cardiography significantly correlated positively with
6MWD in AF patients.Abbreviations
6MWD, 6 min walk distance; 6MWT, 6 min walk test; AF, atrial fibrillation;
ATS, Automatic Test System; BMI, body mass index; CCU, cardiac color
ultrasound; CO, cardiac output; COPD, chronic obstructive pulmonary diseases;
DLVD, diastolic left ventricular diameter; EDV, end-diastolic volume; ICG,
impedance cardiography; IVST, interventricular septal thickness; LAD, left atrial
diameter; LSW, left stroke work; LSWI, left stroke work index; LVEF, left ventricle
ejection fraction; LVPWT, left ventricular posterior wall thickness; NT-pro BNP,
NT-pro brain natriuretic peptide; SSVR, stroke systemic vascular resistance;
SSVRI, stroke systemic vascular resistance index; SV, stroke volume; SVI, stroke
volume index
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